# Drug Eluting Stents In The Critically Ischemic Lower Leg

> **NCT00510393** · PHASE2 · COMPLETED · sponsor: **Flanders Medical Research Program** · enrollment: 140 (actual)

## Conditions studied

- Peripheral Vascular Disease
- Critical Limb Ischemia

## Interventions

- **DEVICE:** XIENCE V everolimus eluting coronary stent system
- **DEVICE:** MULTILINK VISION coronary stent system

## Key facts

- **NCT ID:** NCT00510393
- **Lead sponsor:** Flanders Medical Research Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2010-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510393, "Drug Eluting Stents In The Critically Ischemic Lower Leg". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00510393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*